» Articles » PMID: 12824299

Nanosecond, High-intensity Pulsed Electric Fields Induce Apoptosis in Human Cells

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2003 Jun 26
PMID 12824299
Citations 138
Authors
Affiliations
Soon will be listed here.
Abstract

Electroporation by using pulsed electric fields with long durations compared with the charging time of the plasma membrane can induce cell fusion or introduce xenomolecules into cells. Nanosecond pulse power technology generates pulses with high-intensity electric fields, but with such short durations that the charging time of the plasma membrane is not reached, but intracellular membranes are affected. To determine more specifically their effects on cell structure and function, human cells were exposed to high intensity (up to 300 kV/cm) nanosecond (10-300 ns) pulsed electric fields (nsPEF) and were analyzed at the cellular and molecular levels. As the pulse duration decreased, plasma membrane electroporation decreased and appearances of apoptosis markers were delayed. NsPEF induced apoptosis within tens of minutes, depending on the pulse duration. Annexin-V binding, caspase activation, decreased forward light scatter, and cytochrome c release into the cytoplasm were coincident. Apoptosis was caspase- and mitochondria-dependent but independent of plasma membrane electroporation and thermal changes. The results suggest that with decreasing pulse durations, nsPEF modulate cell signaling from the plasma membrane to intracellular structures and functions. NsPEF technology provides a unique, high-power, energy-independent tool to recruit plasma membrane and/or intracellular signaling mechanisms that can delete aberrant cells by apoptosis.

Citing Articles

Modulating the Cell Death Immune Response for Electroporation Treatments.

David K, Alinezhadbalalami N, Salameh Z, Aycock K, Allen I, Davalos R Bioelectricity. 2024; 6(4):263-271.

PMID: 39712216 PMC: 11656017. DOI: 10.1089/bioe.2024.0019.


Pulsed electric field ablation as a candidate to enhance the anti-tumor immune response to immune checkpoint inhibitors.

Arciga B, Walters D, Kimchi E, Staveley-OCarroll K, Li G, Teixeiro E Cancer Lett. 2024; 609:217361.

PMID: 39608443 PMC: 11625606. DOI: 10.1016/j.canlet.2024.217361.


Advances in irreversible electroporation for prostate cancer.

Liu X, Wang H, Zhao Z, Zhong Q, Wang X, Liu X Discov Oncol. 2024; 15(1):713.

PMID: 39589586 PMC: 11599553. DOI: 10.1007/s12672-024-01570-4.


Good manufacturing practice-grade generation of CD19 and CD123-specific CAR-T cells using piggyBac transposon and allogeneic feeder cells in patients diagnosed with B-cell non-Hodgkin lymphoma and acute myeloid leukemia.

Mucha M, Stach M, Kastankova I, Rychla J, Vydra J, Lesny P Front Immunol. 2024; 15:1415328.

PMID: 39192973 PMC: 11347927. DOI: 10.3389/fimmu.2024.1415328.


Changes in Mitochondrial Membrane Potential in Electroporation with Nano- and Microsecond Pulses.

Polajzer T, Peng W, Yao C, Miklavcic D Bioelectricity. 2024; 6(2):97-107.

PMID: 39119574 PMC: 11305006. DOI: 10.1089/bioe.2024.0007.